Cargando…
Vaccination against COVID-19 in a haemodialysis centre: what is the risk of bleeding complications?
Autores principales: | Giot, Matthieu, Robert, Thomas, Brunet, Philippe, Resseguier, Noémie, Lano, Guillaume |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989515/ https://www.ncbi.nlm.nih.gov/pubmed/34429940 http://dx.doi.org/10.1093/ckj/sfab059 |
Ejemplares similares
-
Spike and neutralizing antibodies response to COVID-19 vaccination in haemodialysis patients
por: Giot, Matthieu, et al.
Publicado: (2021) -
Antibody response to SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients and in-centre and satellite centre haemodialysis patients
por: Bertrand, Dominique, et al.
Publicado: (2021) -
Increased risk of COVID-19 in haemodialysis healthcare workers in a tertiary centre in the North West of England
por: Gray, S., et al.
Publicado: (2020) -
COVID-19 vaccine acceptance among haemodialysis patients: a French survey
por: Andrian, Titus, et al.
Publicado: (2021) -
Heterogeneous neutralizing antibodies production after SARS-CoV-2 vaccination in haemodialysis patients
por: Lamy, Gaspard, et al.
Publicado: (2021)